Key Points Stanley Druckenmiller is known for bold moves: Over the past couple of years, he sold all of his shares of Nvidia and Palantir Technologies. Druckenmiller favors technology and healthcare stocks. 10 stocks we like better than Amazon › Billionaires, like the rest of us investors, generally like to be the first to spot a market trend and bet on it early. And since they've proven their inv...
Key Points Stanley Druckenmiller is known for bold moves: Over the past couple of years, he sold all of his shares of Nvidia and Palantir Technologies. Druckenmiller favors technology and healthcare stocks. 10 stocks we like better than Amazon › Billionaires, like the rest of us investors, generally like to be the first to spot a market trend and bet on it early. And since they've proven their investing expertise over time, their moves might inspire us as we choose stocks for our own portfolios. Stanley Druckenmiller is a fantastic billionaire to watch, as he delivered many years of success at Duquesne Capital Management. Over three decades, he generated an average annual return of 30%, and importantly, he didn't lose money during any of those years. These days, Druckenmiller, who retired many years ago, applies his investing knowledge as he selects stocks for the Duquesne Family Office. Here, he oversees $4 billion in securities, and though he invests in a wide variety of industries, his top two are healthcare and technology. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » This offers the billionaire safety, thanks to the healthcare players, and growth, thanks to the tech focus. But in recent times, one healthcare player in particular has offered growth worthy of a top tech player. This company is a leader in a market that analysts say may reach nearly $100 billion by the end of the decade. In a move that may surprise you, Druckenmiller dumped all of his shares in this company and opened positions in three artificial intelligence (AI) giants. Does the billionaire know something Wall Street doesn't? Let's find out. Druckenmiller's latest 13F So, how do we know about Druckenmiller's moves? Managers of more than $100 million in U.S. securities must report trading activity on a quarterly basis on Form 13F. This offers us a look at what they've been doing -- and, if the decisions fit ...
(RTTNews) - Cognizant Technology Solutions Corp. (CTSH) reported a profit for its fourth quarter that Increases, from last year The company's bottom line came in at $648 million, or $1.34 per share. This compares with $546 million, or $1.10 per share, last year. Excluding items, Cognizant Technology Solutions Corp. reported adjusted earnings of $651 million or $1.35 per share for the period. The c...
(RTTNews) - Cognizant Technology Solutions Corp. (CTSH) reported a profit for its fourth quarter that Increases, from last year The company's bottom line came in at $648 million, or $1.34 per share. This compares with $546 million, or $1.10 per share, last year. Excluding items, Cognizant Technology Solutions Corp. reported adjusted earnings of $651 million or $1.35 per share for the period. The company's revenue for the period rose 4.9% to $5.333 billion from $5.082 billion last year. Cognizant Technology Solutions Corp. earnings at a glance (GAAP) : -Earnings: $648 Mln. vs. $546 Mln. last year. -EPS: $1.34 vs. $1.10 last year. -Revenue: $5.333 Bln vs. $5.082 Bln last year. -Guidance: Next quarter revenue guidance: $ 5.36 B To $ 5.44 B The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Kennametal press release ( KMT ): Q2 Non-GAAP EPS of $0.47 beats by $0.09 . Revenue of $530M (+10.0% Y/Y) beats by $7.08M . The Company's expectations for the third quarter of fiscal 2026 and the full year are as follows: Quarterly Outlook: Sales expected to be $545 - $565 million (vs. consensus of $544.24B) Adjusted EPS is expected to be $0.50 - $0.60 (vs. consensus of $0.53) Annual Outlook: Sale...
Kennametal press release ( KMT ): Q2 Non-GAAP EPS of $0.47 beats by $0.09 . Revenue of $530M (+10.0% Y/Y) beats by $7.08M . The Company's expectations for the third quarter of fiscal 2026 and the full year are as follows: Quarterly Outlook: Sales expected to be $545 - $565 million (vs. consensus of $544.24B) Adjusted EPS is expected to be $0.50 - $0.60 (vs. consensus of $0.53) Annual Outlook: Sales expected to be $2.190 - $2.250 billion (vs. consensus of $2.13B) Adjusted EPS is expected to be $2.05 - $2.45 (vs. consensus of $1.66) Free operating cash flow of approximately 60 percent of adjusted net income Capital spending expected to be approximately $90 million More on Kennametal Kennametal Remains A Top-Cut Prospect Kennametal: Fundamentals Improving, But Caution Required Until Bullish Trend Is Established Kennametal Inc. 2026 Q1 - Results - Earnings Call Presentation Kennametal Q2 2026 Earnings Preview Seeking Alpha’s Quant Rating on Kennametal
By Mike Dolan Feb 4 - What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets The AI wave clearly doesn't float all boats. Tuesday's withering shakeout in the shares of software, data analytics and professional services operations shows how new AI development can cut both ways. Other tech firms also suffered, with Microsoft hit again and AMD down sharply ...
By Mike Dolan Feb 4 - What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets The AI wave clearly doesn't float all boats. Tuesday's withering shakeout in the shares of software, data analytics and professional services operations shows how new AI development can cut both ways. Other tech firms also suffered, with Microsoft hit again and AMD down sharply out of hours despite a forecast-beating headline earnings beat. Against that backdrop, Walmart - an early adopter of AI in its processes - became the first retailer ever to top $1 trillion in market valuation on Tuesday. This caps off a year-long rally which has seen its shares soar nearly 26%, vaulting it into the ranks of the tech heavyweights. I’ll get into that and more below. But first, check out my latest column on why Australia's recent rate hike may be a wakeup call for global central banks And listen to the latest episode of the Morning Bid daily podcast. Subscribe to hear Reuters journalists discuss the biggest news in markets and finance seven days a week. AI SCATTERS THE TECH HERD The trigger for the ongoing selloff in global software stocks was actually news from last Friday that AI firm Anthropic had launched a new AI “agent” for automating work tasks. The fact that it took almost two full trading days to land shows how much it blindsided investors, even though recent months have seen markets discriminate much more ruthlessly between winners and losers from AI in the digital and tech space. Alphabet's results after Wednesday's bell will test the mood further. After major Wall Street indexes lost about 1% or so on Tuesday, Nasdaq futures remained in the red early today. Around the world the tech herd was similarly scattered, with hardware and chip firms in Asia continuing to do well but software firms in India also getting caught in the downdraft. Elsewhere, European pharma giant Novo Nordisk slumped almost 20% after the Wegovy maker warned about this year...
(RTTNews) - LEAR CORP (LEA) announced earnings for fourth quarter that Drops, from last year The company's bottom line totaled $82.7 million, or $1.58 per share. This compares with $88.1 million, or $1.61 per share, last year. Excluding items, LEAR CORP reported adjusted earnings of $179.2 million or $3.41 per share for the period. The company's revenue for the period rose 4.8% to $5.988 billion f...
(RTTNews) - LEAR CORP (LEA) announced earnings for fourth quarter that Drops, from last year The company's bottom line totaled $82.7 million, or $1.58 per share. This compares with $88.1 million, or $1.61 per share, last year. Excluding items, LEAR CORP reported adjusted earnings of $179.2 million or $3.41 per share for the period. The company's revenue for the period rose 4.8% to $5.988 billion from $5.714 billion last year. LEAR CORP earnings at a glance (GAAP) : -Earnings: $82.7 Mln. vs. $88.1 Mln. last year. -EPS: $1.58 vs. $1.61 last year. -Revenue: $5.988 Bln vs. $5.714 Bln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Cognizant Technology press release ( CTSH ): Q4 Non-GAAP EPS of $1.35 beats by $0.03 . Revenue of $5.33B (+4.9% Y/Y) beats by $20M . Trailing 12-month bookings of $28.4 billion increased 5% year-over-year, driven by 9% growth in the fourth quarter; 28 large deals signed in 2025, including 12 in the fourth quarter. In 2026, expect to return $1.6 billion to shareholders through share repurchases and...
Cognizant Technology press release ( CTSH ): Q4 Non-GAAP EPS of $1.35 beats by $0.03 . Revenue of $5.33B (+4.9% Y/Y) beats by $20M . Trailing 12-month bookings of $28.4 billion increased 5% year-over-year, driven by 9% growth in the fourth quarter; 28 large deals signed in 2025, including 12 in the fourth quarter. In 2026, expect to return $1.6 billion to shareholders through share repurchases and dividends, including $1 billion of share repurchases. Cash dividend increased 6.5% to $0.33 per share for Q1 2026. First Quarter and Full-Year 2026 Guidance 2 (all growth rates year-over-year) First quarter revenue is expected to be $5.36 to $5.44 billion vs. $5.35B consensus , growth of 4.8% to 6.3%, or 2.7% to 4.2% in constant currency. Full-year 2026 revenue is expected to be $22.14 to $22.66 billion vs. $22.13B consensus , growth of 4.9% to 7.4%, or 4.0% to 6.5% in constant currency. Full-year 2026 Adjusted Operating Margin 3 is expected to be approximately 15.9% to 16.1%, or 10 to 30 basis points of expansion. Full-year 2026 Adjusted Diluted EPS 3 is expected to be in the range of $5.56 to $5.70 vs. $5.63 consensus , growth of 5% to 8%. More on Cognizant Technology Cognizant: Stable Cash Flows Despite Gross Margin Decline Cognizant Technology Solutions: Recent Acquisition And Proposed India Listing Draw Attention Cognizant Technology Q4 2025 Earnings Preview Deutsche upgrades Cognizant to Buy ahead of Q4 earnings Seeking Alpha’s Quant Rating on Cognizant Technology
onurdongel/iStock via Getty Images AzmanL/E+ via Getty Images Hain Celestial ( HAIN ) announced this week that it is divesting its North America snacks business to improve on the profitability of its portfolio and refocus capital on higher-margin core categories while reducing leverage. The company is selling the unit to Canadian, family-owned snacks manufacturer Snackruptors in a 115 million doll...
onurdongel/iStock via Getty Images AzmanL/E+ via Getty Images Hain Celestial ( HAIN ) announced this week that it is divesting its North America snacks business to improve on the profitability of its portfolio and refocus capital on higher-margin core categories while reducing leverage. The company is selling the unit to Canadian, family-owned snacks manufacturer Snackruptors in a 115 million dollar all-cash transaction that is expected to close around February 28/ The deal includes prominent brands such as Garden Veggie Snacks, Terra chips, and Garden of Eatin’ snacks, which collectively accounted for roughly 22% of Hain’s fiscal 2025 net sales and about 38% of its North America segment sales, yet contributed negligible EBITDA over the past 12 months and weighed on consolidated margins. Hain ( HAIN ) management described the divestiture as a decisive step to sharpen the company’s strategic focus, using the proceeds primarily to pay down debt and to reinvest behind higher-margin, higher-growth platforms such as tea, yogurt, baby, and kids’ food, and culinary oils, including brands like Celestial Seasonings, The Greek Gods, Earth’s Best Organic, and Spectrum. Mizuho analyst John Baumgartner said that the deal is likely viewed by the Street as a positive in the short term since proceeds will be utilized to reduce debt. DA Davidson analyst Brian Holland called the divestiture a constructive first step in either reshaping the portfolio or ultimately selling the company entirely. "While a few years ago Snacks appeared a valuable asset, category deceleration and HAIN underperformance therein render these brands less strategic today. To be sure, the company still has a lot of work to do, but for now today's announcement suggests there is indeed optionality for HAIN to explore," updated Holland. Shares of Hain Celestial ( HAIN ) are up 12.2% on a year-to-date basis. Short interest on HAIN stands at 8.9% of the total float. The market cap for the food stock is just over $112...
Boston Scientific press release ( BSX ): Q4 Non-GAAP EPS of $0.80 beats by $0.02 . Revenue of $5.29B (+16.0% Y/Y) beats by $10M . Achieved the following net sales growth in each reportable segment, compared to the prior year period: MedSurg: 11.7 percent reported, 10.2 percent operational and 6.5 percent organic Cardiovascular: 18.2 percent reported, 16.5 percent operational and 16.1 percent organ...
Boston Scientific press release ( BSX ): Q4 Non-GAAP EPS of $0.80 beats by $0.02 . Revenue of $5.29B (+16.0% Y/Y) beats by $10M . Achieved the following net sales growth in each reportable segment, compared to the prior year period: MedSurg: 11.7 percent reported, 10.2 percent operational and 6.5 percent organic Cardiovascular: 18.2 percent reported, 16.5 percent operational and 16.1 percent organic The company estimates net sales growth for the full year 2026, versus the prior year period, to be approximately 10.5 to 11.5 percent on a reported basis and 10.0 to 11.0 percent on an organic basis. Full year organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to certain acquisitions and divestitures for which there are less than a full period of comparable net sales. The company estimates adjusted EPS, excluding certain charges (credits), of $3.43 to $3.49 vs. $3.47 consensus The company estimates net sales growth for the first quarter of 2026, versus the prior year period, to be approximately 10.5 to 12.0 percent on a reported basis and 8.5 to 10.0 percent on an organic basis. First quarter organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to certain acquisitions and divestitures for which there are less than a full period of comparable net sales. The company estimates adjusted EPS, excluding certain charges (credits), of $0.78 to $0.80 vs. $0.80 consensus More on Boston Scientific Boston Scientific: Adding Another Growth Engine With Penumbra Boston Scientific's Bet On Penumbra Isn't To My Liking Boston Scientific: Reclaiming Neurovascular Dominance Through Thrombectomy Precision Boston Scientific Q4 2025 Earnings Preview ClearBridge Appreciation Strategy adds LHX, BSX, and ASMIY; exits CP, LEN, and TXN among Q4 moves
Lear press release ( LEA ): Q4 Non-GAAP EPS of $3.41 beats by $0.61 . Revenue of $6B (+5.3% Y/Y) beats by $200M . Full Year 2026 Financial Outlook Net Sales $23,210 million - $24,010 million (vs. consensus of 23.07B) Core Operating Earnings $1,030 million - $1,200 million Adjusted EBITDA $1,650 million - $1,820 million Restructuring Costs ≈$175 million Operating Cash Flow $1,210 million - $1,310 m...
Lear press release ( LEA ): Q4 Non-GAAP EPS of $3.41 beats by $0.61 . Revenue of $6B (+5.3% Y/Y) beats by $200M . Full Year 2026 Financial Outlook Net Sales $23,210 million - $24,010 million (vs. consensus of 23.07B) Core Operating Earnings $1,030 million - $1,200 million Adjusted EBITDA $1,650 million - $1,820 million Restructuring Costs ≈$175 million Operating Cash Flow $1,210 million - $1,310 million Capital Spending ≈$660 million Free Cash Flow $550 million - $650 million Click to enlarge More on Lear Lear: A Solid Choice In Automotive Parts Lear: Becoming Bullish On Better Prospects (Rating Upgrade) Lear Corporation (LEA) Presents at Goldman Sachs Industrials & Autos Week Transcript Lear Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Lear
Equifax press release ( EFX ): Q4 GAAP EPS of $1.44 misses by $0.23 . Revenue of $1.55B (+9.2% Y/Y) beats by $20M . Issuing full-year 2026 guidance midpoint expectation for revenue of $6.72 billion, up about 10.5%, with constant currency organic revenue growth of about 10% and Adjusted EPS of $8.50 per share. This reflects an assumption that the U.S. mortgage market is down low single digits in 20...
Equifax press release ( EFX ): Q4 GAAP EPS of $1.44 misses by $0.23 . Revenue of $1.55B (+9.2% Y/Y) beats by $20M . Issuing full-year 2026 guidance midpoint expectation for revenue of $6.72 billion, up about 10.5%, with constant currency organic revenue growth of about 10% and Adjusted EPS of $8.50 per share. This reflects an assumption that the U.S. mortgage market is down low single digits in 2026 as well as an assumption that 100% of mortgage credit scores will be FICO Scores. FY26 net sales consensus of $6.60B, EPS consensus of $8.69 More on Equifax Equifax Stock Faces Long-Term Headwinds Despite Positive Q4 Outlook Equifax Inc. (EFX) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript Equifax Inc. (EFX) Presents at J.P. Morgan 2025 Ultimate Services Investor Conference Transcript Equifax Q4 2025 Earnings Preview Equifax stock slumps after senators warn against Medicaid profiteering
Cencora press release ( COR ): Q1 Non-GAAP EPS of $4.08 beats by $0.04 . Revenue of $85.9B (+5.4% Y/Y) misses by $270M . Adjusted Diluted EPS Guidance Range Reaffirmed at $17.45 to $17.75 for Fiscal 2026 More on Cencora Cencora: High-Growth Specialty Services Firm Disguised As A Distributor Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Cencora, Inc. (COR...
Cencora press release ( COR ): Q1 Non-GAAP EPS of $4.08 beats by $0.04 . Revenue of $85.9B (+5.4% Y/Y) misses by $270M . Adjusted Diluted EPS Guidance Range Reaffirmed at $17.45 to $17.75 for Fiscal 2026 More on Cencora Cencora: High-Growth Specialty Services Firm Disguised As A Distributor Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Cencora Q1 2026 Earnings Preview CD&R, TPG's Covetrus in talks to buy Cencora's vet business - report
Ana Botin has never hidden her ambition to build Banco Santander SA into a leading US bank. On Tuesday, she said she’ll spend $12 billion to get there. The proposed purchase of Webster Financial Corp. — set to be one of the largest US takeovers ever carried out by a European bank — caps a dealmaking blitz from the executive chair since spring last year. Botin is using a higher share price and proc...
Ana Botin has never hidden her ambition to build Banco Santander SA into a leading US bank. On Tuesday, she said she’ll spend $12 billion to get there. The proposed purchase of Webster Financial Corp. — set to be one of the largest US takeovers ever carried out by a European bank — caps a dealmaking blitz from the executive chair since spring last year. Botin is using a higher share price and proceeds from the sale of a Polish bank stake to scale up in the UK and now the US. “This is a strategically important acquisition because it drives us to our goal, which is to be one of the most profitable banks” in the US, Botin said Wednesday on Bloomberg TV. The larger US footprint has been years in the making. As part of the effort, Botin has been boosting ranks in the investment bank and rolling out digital banking offerings. Despite all that, Santander only has about 4 million active customers in the US, roughly 4% of its total, according to its 2025 annual report. That compares with 12 million in Mexico and 34 million in Brazil. The Webster transaction would give the lender a full-blown bank offering in the US Northeast, including about 200 branches and $84 billion in assets. It would also add more than five million customers, according to a Santander spokesperson, who said many are from the healthcare sector and many others are companies. Mixed Response Santander expects the Webster takeover, which still needs to be accepted by shareholders, to nearly double its profitability in the US by 2028. It also anticipates cost synergies of about $800 million, equivalent to almost a fifth of the combined US cost base. The US bank’s $69 billion in deposits are expected to help Santander fund its auto finance business. Webster’s investors will receive $48.75 per share in cash and 2.0548 Santander shares in the form of American Depositary Shares per Webster share. The plans have met with a mixed response from analysts and shareholders, who sent Santander shares down as much as 5%....
00:00 Speaker A you hit upon something that I really wanted to ask you about, which is sort of Palantier versus everybody else within software. As you well know, most software stocks have had a very rough go of it for really the past at least six months, if not longer. Palantier started to get rough towards the, you know, the end of that period, but it really hasn't traded like its cohort. And do ...
00:00 Speaker A you hit upon something that I really wanted to ask you about, which is sort of Palantier versus everybody else within software. As you well know, most software stocks have had a very rough go of it for really the past at least six months, if not longer. Palantier started to get rough towards the, you know, the end of that period, but it really hasn't traded like its cohort. And do you think that that is justified? Do you think software broadly is going to continue to muddle along even as Palantier continues to grow? 00:39 Speaker B Uh we actually think that software companies are overly maligned right now. They do provide very valuable services to their customers. They're still very good businesses growing fast with the with good margins that that can scale well and are hard to switch out of. The the software business is still good. We understand concerns about AI. We're in a period of uncertainty. But the answer that includes Palantier is good software companies will execute well as this technology disruption happens and will win. Bad software companies will falter. This is like 30 years ago when when we started uh buying things online, Best Buy and Circuit City were in the same boat. And here we are today. Best Buy is a big thriving business and Circuit City's been bankrupt for 25 years. Good software companies will succeed in the era of AI and there's no better software company than Palante. So I guess to 01:32 Speaker A So, I guess to oversimplify it, what separates a good software company from a bad software company? Is it just what you talked about earlier that Palantier comes to a company and says, we can solve your problem, and they actually solve it, and maybe not everyone is doing that to the same degree right now. 01:53 Speaker B That's right. So a good software company is the company that's market leader that helps their customers solve problems and importantly, helps their customers adopt a new solution. So I'll give you a couple of exam...
It's not too late to buy these stocks at a great price before they take off. After strong returns in each of the last three years, the S&P 500 might look a bit expensive for some investors. Growth stocks have led the market higher, and overall valuations have climbed higher as a result. Finding a good price on a wonderful business that can keep growing isn't nearly as easy today as it was in the d...
It's not too late to buy these stocks at a great price before they take off. After strong returns in each of the last three years, the S&P 500 might look a bit expensive for some investors. Growth stocks have led the market higher, and overall valuations have climbed higher as a result. Finding a good price on a wonderful business that can keep growing isn't nearly as easy today as it was in the doldrums of the last bear market. But there are still opportunities out there to invest in growth stocks, even if you only have $250 to get started. These three companies all sport attractive prices relative to their growth potential, making them no-brainers for investors looking for new stocks to buy. 1. Palo Alto Networks Palo Alto Networks (PANW 5.25%) is a leading cybersecurity provider with a growing assortment of software solutions to complement its original hardware firewall systems. It's expanded aggressively with acquisitions like CyberArk and Chronosphere to take advantage of the growing trend of enterprises consolidating their cybersecurity needs with a single provider. As cybersecurity needs expand with growing amounts of enterprise data and workers who need access to systems and information from remote locations, Palo Alto is well positioned to deliver cybersecurity solutions for just about everything a business needs. That should enable it to outpace the fast-growing industry, although it comes with significant upfront costs to develop or acquire new solutions. Expand NASDAQ : PANW Palo Alto Networks Today's Change ( -5.25 %) $ -9.21 Current Price $ 166.21 Key Data Points Market Cap $116B Day's Range $ 163.34 - $ 174.55 52wk Range $ 144.15 - $ 223.61 Volume 54 Avg Vol 6.1M Gross Margin 73.47 % The good news for investors is that the shift toward software-based solutions means Palo Alto Networks should see strong margin expansion. That's especially true if it can get existing customers to take more of its services. It saw 23% year-over-year growth in software pr...
The Two Levels Of EU-Sanctions Illegality Submitted by Pascal Lottaz Pascal’s Note: A previous guest on my YouTube Channel, Luis Roberto Zamora Bolaños—the international lawyer who, back in the 2000s, forced his native Costa Rica to withdraw from George W. Bush’s Coalition of the Willing—sent me a short assessment of the legality of EU sanctions. He argues that the Eurocrats are, in fact, grossly ...
The Two Levels Of EU-Sanctions Illegality Submitted by Pascal Lottaz Pascal’s Note: A previous guest on my YouTube Channel, Luis Roberto Zamora Bolaños—the international lawyer who, back in the 2000s, forced his native Costa Rica to withdraw from George W. Bush’s Coalition of the Willing—sent me a short assessment of the legality of EU sanctions. He argues that the Eurocrats are, in fact, grossly overstepping their competencies under international law. Not only are the sanctions in breach of the law between nations, but they are also a heavy infringement on the Human Rights of the targeted people. Here is his verdict. Unilateral Sanctions against States are Illegal. Can states do whatever they want within their own borders and jurisdictions? On the one hand, under the Lotus Principle , states (and more generally, subjects of international law) are indeed allowed to act freely as long as they don’t contravene other rules of international law, customary rules, or peremptory norms. Nonetheless, the freedom of action of a subject of international law (IL) is limited by the rights of other States, most notably the principle of sovereignty. While unilateral acts like sanctions are not explicitly codified in IL, that doesn’t mean they are unrecognized or exempt from scrutiny. The International Court of Justice (ICJ) has dealt with them in several cases, most notably the Nuclear Tests case (also in the UK-NOR Fisheries Case). Moreover, in 2006, the United Nations International Law Commission (ILC) issued its “Guiding Principles applicable to unilateral declarations of States capable of creating legal obligations,” which should be fully applicable to other subjects of international law. Principle 9 establishes that: No obligation may result for other States from the unilateral declaration of a State. However, the other State or States concerned may incur obligations in relation to such a unilateral declaration to the extent that they clearly accepted such a declaration. In i...
(RTTNews) - GE HealthCare Technologies Inc. (GEHC) reported earnings for fourth quarter that Drops, from the same period last year The company's earnings totaled $589 million, or $1.29 per share. This compares with $720 million, or $1.57 per share, last year. Excluding items, GE HealthCare Technologies Inc. reported adjusted earnings of $659 million or $1.44 per share for the period. The company's...
(RTTNews) - GE HealthCare Technologies Inc. (GEHC) reported earnings for fourth quarter that Drops, from the same period last year The company's earnings totaled $589 million, or $1.29 per share. This compares with $720 million, or $1.57 per share, last year. Excluding items, GE HealthCare Technologies Inc. reported adjusted earnings of $659 million or $1.44 per share for the period. The company's revenue for the period rose 7.1% to $5.698 billion from $5.319 billion last year. GE HealthCare Technologies Inc. earnings at a glance (GAAP) : -Earnings: $589 Mln. vs. $720 Mln. last year. -EPS: $1.29 vs. $1.57 last year. -Revenue: $5.698 Bln vs. $5.319 Bln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.